Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Blaise

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
European Cytokine Network|February 27, 2008
Interleukin-21 is associated with IgG1 and IgG3 antibodies to erythrocyte-binding antigen-175 peptide 4 of Plasmodium falciparum in Gabonese children with acute falciparum malariaLudovic Mewono, Davy W Matondo Maya, Pierre-Blaise Matsiegui, et al.
The Journal of Infectious Diseases|February 21, 2004
Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African childrenSteffen Borrmann, Ayola A Adegnika, Pierre-Blaise Matsiegui, et al.
The American Journal of Tropical Medicine and Hygiene|March 18, 2005
Short report: Piloting paperless data entry for clinical research in AfricaMichel A Missinou, Christopher H O Olola, Saadou Issifou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2002
Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccinesJean-François Faucher, Ronnie Binder, Michel A Missinou, et al.
Plos Neglected Tropical Diseases|October 2, 2015
Classification of Rhinoentomophthoromycosis into Atypical, Early, Intermediate, and Late Disease: A ProposalChristian G Blumentrath, Martin P Grobusch, Pierre-Blaise Matsiégui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2003
Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young childrenSteffen Borrmann, Jean-François Faucher, Thierry Bagaphou, et al.
Lancet (London, England)|December 21, 2002
Fosmidomycin for malariaMichel A Missinou, Steffen Borrmann, Andreas Schindler, et al.
Cellular and Molecular Life Sciences : CMLS|August 12, 2010
Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularizationJulie Lecomte, Krystel Louis, Benoit Detry, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malariaSteffen Borrmann, Ingrid Lundgren, Sunny Oyakhirome, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in GabonSteffen Borrmann, Ayola A Adegnika, Michel A Missinou, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
European Cytokine Network|February 27, 2008
Interleukin-21 is associated with IgG1 and IgG3 antibodies to erythrocyte-binding antigen-175 peptide 4 of Plasmodium falciparum in Gabonese children with acute falciparum malariaLudovic Mewono, Davy W Matondo Maya, Pierre-Blaise Matsiegui, et al.
The Journal of Infectious Diseases|February 21, 2004
Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African childrenSteffen Borrmann, Ayola A Adegnika, Pierre-Blaise Matsiegui, et al.
The American Journal of Tropical Medicine and Hygiene|March 18, 2005
Short report: Piloting paperless data entry for clinical research in AfricaMichel A Missinou, Christopher H O Olola, Saadou Issifou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2002
Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccinesJean-François Faucher, Ronnie Binder, Michel A Missinou, et al.
Plos Neglected Tropical Diseases|October 2, 2015
Classification of Rhinoentomophthoromycosis into Atypical, Early, Intermediate, and Late Disease: A ProposalChristian G Blumentrath, Martin P Grobusch, Pierre-Blaise Matsiégui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2003
Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young childrenSteffen Borrmann, Jean-François Faucher, Thierry Bagaphou, et al.
Lancet (London, England)|December 21, 2002
Fosmidomycin for malariaMichel A Missinou, Steffen Borrmann, Andreas Schindler, et al.
Cellular and Molecular Life Sciences : CMLS|August 12, 2010
Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularizationJulie Lecomte, Krystel Louis, Benoit Detry, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malariaSteffen Borrmann, Ingrid Lundgren, Sunny Oyakhirome, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in GabonSteffen Borrmann, Ayola A Adegnika, Michel A Missinou, et al.
Pageof 7